[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CY1116060T1 - Heterocyclic Compounds as Inhibitors of Virus C (HCV) - Google Patents

Heterocyclic Compounds as Inhibitors of Virus C (HCV)

Info

Publication number
CY1116060T1
CY1116060T1 CY20151100050T CY151100050T CY1116060T1 CY 1116060 T1 CY1116060 T1 CY 1116060T1 CY 20151100050 T CY20151100050 T CY 20151100050T CY 151100050 T CY151100050 T CY 151100050T CY 1116060 T1 CY1116060 T1 CY 1116060T1
Authority
CY
Cyprus
Prior art keywords
hcv
virus
inhibitors
heterocyclic compounds
compounds
Prior art date
Application number
CY20151100050T
Other languages
Greek (el)
Inventor
John T Randolph
Mark A Matulenko
Ryan G Keddy
Tammie K Jinkerson
Douglas K Hutchinson
Charles A Flentge
Rolf Wagner
Clarence J Maring
Michael D Tufano
David A Betebenner
Todd W Rockway
David A Degoey
Dachun Liu
John K Pratt
Kathy Sarris
Kevin R Woller
Seble H Wagaw
Jean C Califano
Wenke Li
Daniel D Caspi
Mary E Bellizzi
Yi Gao
Warren M Kati
Charles W Hutchins
Pamela L Donner
Allan C Krueger
Christopher E Motter
Lissa T Nelson
Sachin V Patel
Original Assignee
Abbvie Bahamas Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20120155991 external-priority patent/EP2455376B1/en
Application filed by Abbvie Bahamas Ltd. filed Critical Abbvie Bahamas Ltd.
Publication of CY1116060T1 publication Critical patent/CY1116060T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Περιγράφονται ενώσεις αποτελεσματικές στην αναστολή αντιγραφής του ιού ηπατίτιδας C («HCV»). Η εφεύρεση αυτή επίσης αφορά σε μεθόδους κατασκευής τέτοιων ενώσεων, συνθέσεις που περιλαμβάνουν τέτοιες ενώσεις και μεθόδους χρήσης τέτοιων ενώσεων για να θεραπεύεται μόλυνση HCV.Compounds effective in inhibiting replication of hepatitis C virus ("HCV") are described. This invention also relates to methods of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

CY20151100050T 2009-06-11 2015-01-16 Heterocyclic Compounds as Inhibitors of Virus C (HCV) CY1116060T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18629109A 2009-06-11 2009-06-11
US24283609A 2009-09-16 2009-09-16
US24359609A 2009-09-18 2009-09-18
EP20120155991 EP2455376B1 (en) 2009-06-11 2010-06-10 Heterocyclic compounds as inhibitors of hepatitis C virus (HCV)

Publications (1)

Publication Number Publication Date
CY1116060T1 true CY1116060T1 (en) 2017-03-15

Family

ID=58459720

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20151100050T CY1116060T1 (en) 2009-06-11 2015-01-16 Heterocyclic Compounds as Inhibitors of Virus C (HCV)
CY20161100372T CY1117456T1 (en) 2009-06-11 2016-05-05 TRIPPILIZED HETEROCYCLES AS CATCHVAC VIRUS replica inhibitors

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20161100372T CY1117456T1 (en) 2009-06-11 2016-05-05 TRIPPILIZED HETEROCYCLES AS CATCHVAC VIRUS replica inhibitors

Country Status (1)

Country Link
CY (2) CY1116060T1 (en)

Also Published As

Publication number Publication date
CY1117456T1 (en) 2017-04-26

Similar Documents

Publication Publication Date Title
MY186633A (en) Heterocyclic compounds as inhibitors of hepatitis c virus (hcv)
EA201101082A1 (en) HEPATITIS C VIRUS INHIBITORS
EA201270656A1 (en) HEPATITIS C VIRUS INHIBITORS
EA201171208A1 (en) HEPATITIS C VIRUS INHIBITORS
EA201001273A1 (en) HEPATITIS C VIRUS INHIBITORS
EA201270622A1 (en) HEPATITIS C VIRUS INHIBITORS
EA201001275A1 (en) CONFORMATION-LIMITED BIPHENYL DERIVATIVES FOR USE AS HEPATITIS C VIRUS INHIBITORS
EA200900298A1 (en) HEPATITIS C VIRUS INHIBITORS
ATE551337T1 (en) HEPATITIS C VIRUS INHIBITORS
NO20090453L (en) Hepatitis C Virus Inhibitors
CO6390076A2 (en) NS5A HCV INHIBITORS
CO6390077A2 (en) NS5A HACV INHIBITORS
EA201390538A1 (en) ANTI-VIRUS COMPOUNDS
EA201390190A1 (en) HEPATITIS C VIRUS INHIBITORS
EA201001274A1 (en) IMIDAZOLYL BIPHENYL IMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS
MX2011010905A (en) Anti-viral compounds.
EA201270555A1 (en) COMBINATION OF HEPATITIS C VIRUS INHIBITORS
EA201071315A1 (en) HEPATITIS C VIRUS PROTEASE INHIBITORS
MX346264B (en) Anti-viral compounds.
EA201370017A1 (en) HEPATITIS C VIRUS INHIBITORS
CR20110605A (en) ANTIVIRAL HETEROCYCLIC COMPOUNDS
ATE522532T1 (en) COMPOUNDS FOR TREATING HEPATITIS C
ATE533771T1 (en) CYCLOPROPYL-CONDENSED INDOLOBENZAZEPINES AS HCV-NS5B INHIBITORS
ATE494291T1 (en) COMPOUNDS FOR TREATING HEPATITIS C
EA201000277A1 (en) CONNECTIONS FOR THE TREATMENT OF HEPATITIS C